Lakefront Biotherapeutics NV current report, Q2 FY2021

Business Context and Reporting Period

This Form 6-K filing is submitted by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in metadata) for the month of May 2021, with a specific reporting date of May 18, 2021. The registrant is a foreign private issuer incorporated in Belgium, headquartered in Mechelen. The filing primarily serves to incorporate by reference a press release dated May 18, 2021 (Exhibit 99.1) into the company's active Registration Statements on Forms F-3 and S-8.

Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts as a conduit for a press release rather than a financial statement.

Material Changes

The filing does not detail material financial changes versus prior periods. The primary material event is the issuance of a press release on May 18, 2021, the content of which is attached as Exhibit 99.1 but not summarized in the text of the Form 6-K itself.

Guidance, Outlook, and Risks

The text does not provide specific guidance, outlook, management commentary, or risk factors. It notes that the press release (Exhibit 99.1) contains quotes from Dr. Walid Abi-Saab and Prof. Gerd Burmester, but the substance of these quotes is not included in the filing text provided.

Key Facts for Investor Verification

  • Verify the content of Exhibit 99.1 (Press Release dated May 18, 2021) to understand the specific corporate event or announcement triggering this filing.
  • Confirm the registrant name is Galapagos NV, as the metadata reference to "Lakefront Biotherapeutics NV" appears to be incorrect based on the filing text.
  • Note that this filing incorporates information into multiple active Registration Statements (Forms F-3 and S-8) for potential future securities offerings.
  • Review the full press release for details on the quotes from Dr. Walid Abi-Saab and Prof. Gerd Burmester, as these are excluded from the incorporation by reference in the main text.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.